James Jar­rett

Modern Healthcare - - SPECIAL FEATURE -

Seven years ago, few peo­ple knew about pro­ton ther­apy, a form of ra­di­a­tion that can more pre­cisely tar­get and ir­ra­di­ate a tu­mor. How­ever, that didn’t stop James Jar­rett from tak­ing what he calls a leap of faith to join a fledg­ling com­pany that has now built three pro­ton-ther­apy fa­cil­i­ties and is the largest provider of pro­ton ther­apy in the U.S. Jar­rett, 38, serves as pres­i­dent of the Pro­Cure Pro­ton Ther­apy Cen­ter in Som­er­set, N.J. He joined Pro­Cure Treat­ment Cen­ters, the fa­cil­ity’s par­ent com­pany, as its sec­ond em­ployee in 2005 and has held a num­ber of busi­ness de­vel­op­ment, mar­ket­ing and op­er­a­tions po­si­tions.

“What re­ally in­ter­ests James is how things work, how things can be made bet­ter and how an ex­pe­ri­ence can be im­proved,” says Hadley Ford, Pro­Cure’s CEO.

Jar­rett’s un­der­stand­ing of the fac­tors that drive the pa­tient ex­pe­ri­ence led him to stan­dard­ize the pa­tient in­take process, start­ing with the com­pany’s Ok­la­homa fa­cil­ity, Ford says.

He found that pa­tients first need to be aware of pro­ton ther­apy as a treat­ment op­tion, which makes it im­por­tant that by the time they call a fa­cil­ity that they meet with a physi­cian in a timely man­ner. (There are only 10 pro­ton ther­apy fa­cil­i­ties in the U.S. in op­er­a­tion.) “That ini­tial ob­ser­va­tion less­ened the amount of time it took to get some­one into the pro­ton cen­ter,” Ford says, “and it im­proved the abil­ity of pa­tients to have ac­cess to pro­tons.”

It was Ford who hired Jar­rett, whom he had worked with dur­ing an ear­lier ca­reer in bank­ing. The two worked closely to­gether, with Jar­rett help­ing draft the com­pany’s busi­ness plan and ar­range the orig­i­nal fi­nan­cial plan, which led to the $700 mil­lion in eq­uity cap­i­tal that Pro­Cure has raised since 2005. “It was a pretty big leap of faith, but it was cer­tainly an ex­cit­ing leap and an ex­cit­ing trip so far,” Jar­rett says.

When Jar­rett was con­sid­er­ing his first po­si­tion with Pro­Cure, he spoke with a res­i­dency class­mate of his fa­ther, who is a vas­cu­lar sur­geon. The class­mate, who had worked with pro­ton ther­apy in a lab set­ting in the 1960s, told him that the com­pany could im­pact how ra­di­a­tion ther­apy is de­liv­ered in the U.S.

“To me, that seemed like a pretty worth­while risk to take,” Jar­rett says.

The $160 mil­lion fa­cil­ity in Som­er­set opened this year. Jar­rett notes that pa­tients are start­ing to re­fer other pa­tients and their sat­is­fac­tion scores on post-treat­ment sur­veys are en­cour­ag­ing.

As the only pro­ton ther­apy fa­cil­ity in the great New York metropoli­tan area, Jar­rett noted the op­por­tu­ni­ties for the fa­cil­ity to grow, es­pe­cially with the ad­di­tion of treat­ment for pe­di­atric tu­mors and lung can­cer later this year.

“What re­ally in­ter­ests James is how things work, how things can be made bet­ter and how an ex­pe­ri­ence can be im­proved.”

38, Pres­i­dent, Pro­Cure Pro­ton Ther­apy Cen­ter, Som­er­set, N.J.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.